BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


SEARCH JOBS




Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.


 Key Statistics


Email:
Ownership:

Web Site: Gilead Sciences, Inc.
Employees: 4,000
Symbol: GILD
 



Industry
Biotechnology






 Company News
Achillion Pharmaceuticals, Inc. (ACHN) Hits One Year High After Rumors Gilead Sciences, Inc. (GILD) Might Buy It Out 8/27/2014 6:27:16 AM
Gilead Sciences, Inc. (GILD) Shaky As Achillion Pharmaceuticals, Inc. (ACHN)'s Hepatitis C Drug Cures All Patients In Mid-Stage Trial 8/15/2014 7:12:05 AM
Gilead Sciences, Inc. (GILD) Will Charge $900 For Sovaldi In India 8/8/2014 6:19:07 AM
Gilead Sciences, Inc. (GILD) Battles To Shift Debate Over $1,000 Hepatitis Pills From Costs To Cures 8/5/2014 6:33:42 AM
Gilead Sciences, Inc. (GILD) Popular Amongst Latest 13F Filers 7/31/2014 6:56:16 AM
Theraclone Sciences, Inc. Announces Exclusive Agreement With Gilead Sciences, Inc. (GILD) For Broadly Neutralizing HIV Antibodies 7/30/2014 9:34:50 AM
Gilead Sciences, Inc. (GILD) Allows China/Indian Pharmas To Make Generic Version Of Novel HIV Drug 7/30/2014 8:49:04 AM
Politicizing Gilead Sciences, Inc. (GILD)'s R&D Solvadi Costs Is A Reckless And Dangerous Misadventure 7/28/2014 6:11:16 AM
European CHMP Adopts Positive Opinion For Gilead Sciences, Inc. (GILD)’s Zydelig® (Idelalisib) For The Treatment Of Chronic Lymphocytic Leukemia And Follicular Lymphoma 7/25/2014 9:06:11 AM
Gilead Sciences, Inc. (GILD) Announces Second Quarter 2014 Financial Results 7/24/2014 12:59:13 PM
12345678910...